Pediatrix Medical (MD) EBIT Margin (2016 - 2025)
Pediatrix Medical (MD) has disclosed EBIT Margin for 17 consecutive years, with 23.2% as the latest value for Q4 2025.
- On a quarterly basis, EBIT Margin fell 3102.0% to 23.2% in Q4 2025 year-over-year; TTM through Dec 2025 was 2.37%, a 579.0% increase, with the full-year FY2025 number at 2.37%, up 579.0% from a year prior.
- EBIT Margin was 23.2% for Q4 2025 at Pediatrix Medical, down from 13.81% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 13.81% in Q3 2025 to a low of 31.28% in Q2 2024.
- A 5-year average of 3.76% and a median of 7.89% in 2023 define the central range for EBIT Margin.
- Peak YoY movement for EBIT Margin: plummeted -4096bps in 2024, then surged 4404bps in 2025.
- Pediatrix Medical's EBIT Margin stood at 13.64% in 2021, then crashed by -49bps to 7.01% in 2022, then crashed by -420bps to 22.46% in 2023, then surged by 135bps to 7.82% in 2024, then crashed by -397bps to 23.2% in 2025.
- Per Business Quant, the three most recent readings for MD's EBIT Margin are 23.2% (Q4 2025), 13.81% (Q3 2025), and 12.77% (Q2 2025).